A pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HANMI SCI CO LTD
- Publication Date
- 2010-11-03
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a composition for treating obesity-related diseases comprising an insulin-stimulating peptide conjugate, in particular to a combination for treating obesity-related diseases comprising a conjugate prepared by covalently linking insulin-stimulating peptide and a carrier substance through a non-peptidyl linker Compositions, and methods of using the compositions to treat obesity-related diseases. Background technique
[0002] Obesity is a chronic disease associated with high morbidity and mortality, resulting from the accumulation of adipose tissue due to energy imbalance or overnutrition. Obesity and obesity-related diseases are serious health problems in the United States and around the world. Over the past 7 years, the prevalence of obesity has increased from 22.9% to 30.6% in the general population of the United States. According to the results of the 1999-2002 National Health and Nutrition Examination Survey (NHANES...